Pharma & Healthcare
PD-1 and PD-L1 Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Oct 12, 24
- ID: 163484
- Pages: 145
- Figures: 240
- Views: 11
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
The global market for PD-1 and PD-L1 Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of PD-1 and PD-L1 Drug by region & country, by Type, and by Application.
The PD-1 and PD-L1 Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Drug.
Market Segmentation
By Company
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
Segment by Type:
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Segment by Application
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of PD-1 and PD-L1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of PD-1 and PD-L1 Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of PD-1 and PD-L1 Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for PD-1 and PD-L1 Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of PD-1 and PD-L1 Drug by region & country, by Type, and by Application.
The PD-1 and PD-L1 Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Drug.
Market Segmentation
By Company
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
Segment by Type:
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Segment by Application
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of PD-1 and PD-L1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of PD-1 and PD-L1 Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of PD-1 and PD-L1 Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 PD-1 and PD-L1 Drug Product Introduction
1.2 Global PD-1 and PD-L1 Drug Market Size Forecast
1.2.1 Global PD-1 and PD-L1 Drug Sales Value (2019-2030)
1.2.2 Global PD-1 and PD-L1 Drug Sales Volume (2019-2030)
1.2.3 Global PD-1 and PD-L1 Drug Sales Price (2019-2030)
1.3 PD-1 and PD-L1 Drug Market Trends & Drivers
1.3.1 PD-1 and PD-L1 Drug Industry Trends
1.3.2 PD-1 and PD-L1 Drug Market Drivers & Opportunity
1.3.3 PD-1 and PD-L1 Drug Market Challenges
1.3.4 PD-1 and PD-L1 Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global PD-1 and PD-L1 Drug Players Revenue Ranking (2023)
2.2 Global PD-1 and PD-L1 Drug Revenue by Company (2019-2024)
2.3 Global PD-1 and PD-L1 Drug Players Sales Volume Ranking (2023)
2.4 Global PD-1 and PD-L1 Drug Sales Volume by Company Players (2019-2024)
2.5 Global PD-1 and PD-L1 Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers PD-1 and PD-L1 Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers PD-1 and PD-L1 Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of PD-1 and PD-L1 Drug
2.9 PD-1 and PD-L1 Drug Market Competitive Analysis
2.9.1 PD-1 and PD-L1 Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by PD-1 and PD-L1 Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PD-1 Monoclonal Antibody
3.1.2 PD-L1 Monoclonal Antibody
3.2 Global PD-1 and PD-L1 Drug Sales Value by Type
3.2.1 Global PD-1 and PD-L1 Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global PD-1 and PD-L1 Drug Sales Value, by Type (2019-2030)
3.2.3 Global PD-1 and PD-L1 Drug Sales Value, by Type (%) (2019-2030)
3.3 Global PD-1 and PD-L1 Drug Sales Volume by Type
3.3.1 Global PD-1 and PD-L1 Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global PD-1 and PD-L1 Drug Sales Volume, by Type (2019-2030)
3.3.3 Global PD-1 and PD-L1 Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global PD-1 and PD-L1 Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Liver Cancer
4.1.2 Esophageal Cancer
4.1.3 Nasal Cancer
4.1.4 Stomach Cancer
4.1.5 Other
4.2 Global PD-1 and PD-L1 Drug Sales Value by Application
4.2.1 Global PD-1 and PD-L1 Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global PD-1 and PD-L1 Drug Sales Value, by Application (2019-2030)
4.2.3 Global PD-1 and PD-L1 Drug Sales Value, by Application (%) (2019-2030)
4.3 Global PD-1 and PD-L1 Drug Sales Volume by Application
4.3.1 Global PD-1 and PD-L1 Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global PD-1 and PD-L1 Drug Sales Volume, by Application (2019-2030)
4.3.3 Global PD-1 and PD-L1 Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global PD-1 and PD-L1 Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global PD-1 and PD-L1 Drug Sales Value by Region
5.1.1 Global PD-1 and PD-L1 Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024)
5.1.3 Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030)
5.1.4 Global PD-1 and PD-L1 Drug Sales Value by Region (%), (2019-2030)
5.2 Global PD-1 and PD-L1 Drug Sales Volume by Region
5.2.1 Global PD-1 and PD-L1 Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024)
5.2.3 Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030)
5.2.4 Global PD-1 and PD-L1 Drug Sales Volume by Region (%), (2019-2030)
5.3 Global PD-1 and PD-L1 Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.4.2 North America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.5.2 Europe PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.6.2 Asia Pacific PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.7.2 South America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value
6.2.1 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.3.2 United States PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.4.2 Europe PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.5.2 China PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.6.2 Japan PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.7.2 South Korea PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.8.2 Southeast Asia PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.9.2 India PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Information
7.1.2 Bristol Myers Squibb Introduction and Business Overview
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Product Offerings
7.1.5 Bristol Myers Squibb Recent Development
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Information
7.2.2 Merck & Co., Inc. Introduction and Business Overview
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Product Offerings
7.2.5 Merck & Co., Inc. Recent Development
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Company Information
7.3.2 F. Hoffmann -La Roche Ltd Introduction and Business Overview
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Offerings
7.3.5 F. Hoffmann -La Roche Ltd Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi PD-1 and PD-L1 Drug Product Offerings
7.5.5 Sanofi Recent Development
7.6 Pfizer Inc
7.6.1 Pfizer Inc Company Information
7.6.2 Pfizer Inc Introduction and Business Overview
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Product Offerings
7.6.5 Pfizer Inc Recent Development
7.7 Lilly
7.7.1 Lilly Company Information
7.7.2 Lilly Introduction and Business Overview
7.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lilly PD-1 and PD-L1 Drug Product Offerings
7.7.5 Lilly Recent Development
7.8 Novartis AG
7.8.1 Novartis AG Company Information
7.8.2 Novartis AG Introduction and Business Overview
7.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novartis AG PD-1 and PD-L1 Drug Product Offerings
7.8.5 Novartis AG Recent Development
7.9 GSK
7.9.1 GSK Company Information
7.9.2 GSK Introduction and Business Overview
7.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 GSK PD-1 and PD-L1 Drug Product Offerings
7.9.5 GSK Recent Development
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Company Information
7.10.2 Junshi Biosciences Introduction and Business Overview
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Product Offerings
7.10.5 Junshi Biosciences Recent Development
7.11 Akeso, Inc
7.11.1 Akeso, Inc Company Information
7.11.2 Akeso, Inc Introduction and Business Overview
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Product Offerings
7.11.5 Akeso, Inc Recent Development
7.12 BeiGene
7.12.1 BeiGene Company Information
7.12.2 BeiGene Introduction and Business Overview
7.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 BeiGene PD-1 and PD-L1 Drug Product Offerings
7.12.5 BeiGene Recent Development
7.13 Innovent
7.13.1 Innovent Company Information
7.13.2 Innovent Introduction and Business Overview
7.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Innovent PD-1 and PD-L1 Drug Product Offerings
7.13.5 Innovent Recent Development
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Offerings
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Development
7.15 Cstone
7.15.1 Cstone Company Information
7.15.2 Cstone Introduction and Business Overview
7.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Cstone PD-1 and PD-L1 Drug Product Offerings
7.15.5 Cstone Recent Development
7.16 Henlius
7.16.1 Henlius Company Information
7.16.2 Henlius Introduction and Business Overview
7.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Henlius PD-1 and PD-L1 Drug Product Offerings
7.16.5 Henlius Recent Development
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Company Information
7.17.2 Simcere Pharmaceutical Group Limited Introduction and Business Overview
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Offerings
7.17.5 Simcere Pharmaceutical Group Limited Recent Development
8 Industry Chain Analysis
8.1 PD-1 and PD-L1 Drug Industrial Chain
8.2 PD-1 and PD-L1 Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 PD-1 and PD-L1 Drug Sales Model
8.5.2 Sales Channel
8.5.3 PD-1 and PD-L1 Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 PD-1 and PD-L1 Drug Product Introduction
1.2 Global PD-1 and PD-L1 Drug Market Size Forecast
1.2.1 Global PD-1 and PD-L1 Drug Sales Value (2019-2030)
1.2.2 Global PD-1 and PD-L1 Drug Sales Volume (2019-2030)
1.2.3 Global PD-1 and PD-L1 Drug Sales Price (2019-2030)
1.3 PD-1 and PD-L1 Drug Market Trends & Drivers
1.3.1 PD-1 and PD-L1 Drug Industry Trends
1.3.2 PD-1 and PD-L1 Drug Market Drivers & Opportunity
1.3.3 PD-1 and PD-L1 Drug Market Challenges
1.3.4 PD-1 and PD-L1 Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global PD-1 and PD-L1 Drug Players Revenue Ranking (2023)
2.2 Global PD-1 and PD-L1 Drug Revenue by Company (2019-2024)
2.3 Global PD-1 and PD-L1 Drug Players Sales Volume Ranking (2023)
2.4 Global PD-1 and PD-L1 Drug Sales Volume by Company Players (2019-2024)
2.5 Global PD-1 and PD-L1 Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers PD-1 and PD-L1 Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers PD-1 and PD-L1 Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of PD-1 and PD-L1 Drug
2.9 PD-1 and PD-L1 Drug Market Competitive Analysis
2.9.1 PD-1 and PD-L1 Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by PD-1 and PD-L1 Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PD-1 Monoclonal Antibody
3.1.2 PD-L1 Monoclonal Antibody
3.2 Global PD-1 and PD-L1 Drug Sales Value by Type
3.2.1 Global PD-1 and PD-L1 Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global PD-1 and PD-L1 Drug Sales Value, by Type (2019-2030)
3.2.3 Global PD-1 and PD-L1 Drug Sales Value, by Type (%) (2019-2030)
3.3 Global PD-1 and PD-L1 Drug Sales Volume by Type
3.3.1 Global PD-1 and PD-L1 Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global PD-1 and PD-L1 Drug Sales Volume, by Type (2019-2030)
3.3.3 Global PD-1 and PD-L1 Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global PD-1 and PD-L1 Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Liver Cancer
4.1.2 Esophageal Cancer
4.1.3 Nasal Cancer
4.1.4 Stomach Cancer
4.1.5 Other
4.2 Global PD-1 and PD-L1 Drug Sales Value by Application
4.2.1 Global PD-1 and PD-L1 Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global PD-1 and PD-L1 Drug Sales Value, by Application (2019-2030)
4.2.3 Global PD-1 and PD-L1 Drug Sales Value, by Application (%) (2019-2030)
4.3 Global PD-1 and PD-L1 Drug Sales Volume by Application
4.3.1 Global PD-1 and PD-L1 Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global PD-1 and PD-L1 Drug Sales Volume, by Application (2019-2030)
4.3.3 Global PD-1 and PD-L1 Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global PD-1 and PD-L1 Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global PD-1 and PD-L1 Drug Sales Value by Region
5.1.1 Global PD-1 and PD-L1 Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024)
5.1.3 Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030)
5.1.4 Global PD-1 and PD-L1 Drug Sales Value by Region (%), (2019-2030)
5.2 Global PD-1 and PD-L1 Drug Sales Volume by Region
5.2.1 Global PD-1 and PD-L1 Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024)
5.2.3 Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030)
5.2.4 Global PD-1 and PD-L1 Drug Sales Volume by Region (%), (2019-2030)
5.3 Global PD-1 and PD-L1 Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.4.2 North America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.5.2 Europe PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.6.2 Asia Pacific PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.7.2 South America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa PD-1 and PD-L1 Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value
6.2.1 Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.3.2 United States PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.4.2 Europe PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.5.2 China PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.6.2 Japan PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.7.2 South Korea PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.8.2 Southeast Asia PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India PD-1 and PD-L1 Drug Sales Value, 2019-2030
6.9.2 India PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India PD-1 and PD-L1 Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Information
7.1.2 Bristol Myers Squibb Introduction and Business Overview
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Product Offerings
7.1.5 Bristol Myers Squibb Recent Development
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Information
7.2.2 Merck & Co., Inc. Introduction and Business Overview
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Product Offerings
7.2.5 Merck & Co., Inc. Recent Development
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Company Information
7.3.2 F. Hoffmann -La Roche Ltd Introduction and Business Overview
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Offerings
7.3.5 F. Hoffmann -La Roche Ltd Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi PD-1 and PD-L1 Drug Product Offerings
7.5.5 Sanofi Recent Development
7.6 Pfizer Inc
7.6.1 Pfizer Inc Company Information
7.6.2 Pfizer Inc Introduction and Business Overview
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Product Offerings
7.6.5 Pfizer Inc Recent Development
7.7 Lilly
7.7.1 Lilly Company Information
7.7.2 Lilly Introduction and Business Overview
7.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Lilly PD-1 and PD-L1 Drug Product Offerings
7.7.5 Lilly Recent Development
7.8 Novartis AG
7.8.1 Novartis AG Company Information
7.8.2 Novartis AG Introduction and Business Overview
7.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novartis AG PD-1 and PD-L1 Drug Product Offerings
7.8.5 Novartis AG Recent Development
7.9 GSK
7.9.1 GSK Company Information
7.9.2 GSK Introduction and Business Overview
7.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 GSK PD-1 and PD-L1 Drug Product Offerings
7.9.5 GSK Recent Development
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Company Information
7.10.2 Junshi Biosciences Introduction and Business Overview
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Product Offerings
7.10.5 Junshi Biosciences Recent Development
7.11 Akeso, Inc
7.11.1 Akeso, Inc Company Information
7.11.2 Akeso, Inc Introduction and Business Overview
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Product Offerings
7.11.5 Akeso, Inc Recent Development
7.12 BeiGene
7.12.1 BeiGene Company Information
7.12.2 BeiGene Introduction and Business Overview
7.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 BeiGene PD-1 and PD-L1 Drug Product Offerings
7.12.5 BeiGene Recent Development
7.13 Innovent
7.13.1 Innovent Company Information
7.13.2 Innovent Introduction and Business Overview
7.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Innovent PD-1 and PD-L1 Drug Product Offerings
7.13.5 Innovent Recent Development
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Offerings
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Development
7.15 Cstone
7.15.1 Cstone Company Information
7.15.2 Cstone Introduction and Business Overview
7.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Cstone PD-1 and PD-L1 Drug Product Offerings
7.15.5 Cstone Recent Development
7.16 Henlius
7.16.1 Henlius Company Information
7.16.2 Henlius Introduction and Business Overview
7.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Henlius PD-1 and PD-L1 Drug Product Offerings
7.16.5 Henlius Recent Development
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Company Information
7.17.2 Simcere Pharmaceutical Group Limited Introduction and Business Overview
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Offerings
7.17.5 Simcere Pharmaceutical Group Limited Recent Development
8 Industry Chain Analysis
8.1 PD-1 and PD-L1 Drug Industrial Chain
8.2 PD-1 and PD-L1 Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 PD-1 and PD-L1 Drug Sales Model
8.5.2 Sales Channel
8.5.3 PD-1 and PD-L1 Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. PD-1 and PD-L1 Drug Market Trends
Table 2. PD-1 and PD-L1 Drug Market Drivers & Opportunity
Table 3. PD-1 and PD-L1 Drug Market Challenges
Table 4. PD-1 and PD-L1 Drug Market Restraints
Table 5. Global PD-1 and PD-L1 Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2019-2024)
Table 7. Global PD-1 and PD-L1 Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market PD-1 and PD-L1 Drug Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers PD-1 and PD-L1 Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers PD-1 and PD-L1 Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of PD-1 and PD-L1 Drug
Table 13. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global PD-1 and PD-L1 Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global PD-1 and PD-L1 Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global PD-1 and PD-L1 Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global PD-1 and PD-L1 Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global PD-1 and PD-L1 Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global PD-1 and PD-L1 Drug Price by Type (2019-2024) & (US$/Unit)
Table 27. Global PD-1 and PD-L1 Drug Price by Type (2025-2030) & (US$/Unit)
Table 28. Global PD-1 and PD-L1 Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global PD-1 and PD-L1 Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global PD-1 and PD-L1 Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global PD-1 and PD-L1 Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global PD-1 and PD-L1 Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global PD-1 and PD-L1 Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global PD-1 and PD-L1 Drug Price by Application (2019-2024) & (US$/Unit)
Table 39. Global PD-1 and PD-L1 Drug Price by Application (2025-2030) & (US$/Unit)
Table 40. Global PD-1 and PD-L1 Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global PD-1 and PD-L1 Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global PD-1 and PD-L1 Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global PD-1 and PD-L1 Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Bristol Myers Squibb Company Information
Table 58. Bristol Myers Squibb Introduction and Business Overview
Table 59. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bristol Myers Squibb PD-1 and PD-L1 Drug Product Offerings
Table 61. Bristol Myers Squibb Recent Development
Table 62. Merck & Co., Inc. Company Information
Table 63. Merck & Co., Inc. Introduction and Business Overview
Table 64. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Merck & Co., Inc. PD-1 and PD-L1 Drug Product Offerings
Table 66. Merck & Co., Inc. Recent Development
Table 67. F. Hoffmann -La Roche Ltd Company Information
Table 68. F. Hoffmann -La Roche Ltd Introduction and Business Overview
Table 69. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Offerings
Table 71. F. Hoffmann -La Roche Ltd Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca PD-1 and PD-L1 Drug Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi PD-1 and PD-L1 Drug Product Offerings
Table 81. Sanofi Recent Development
Table 82. Pfizer Inc Company Information
Table 83. Pfizer Inc Introduction and Business Overview
Table 84. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Inc PD-1 and PD-L1 Drug Product Offerings
Table 86. Pfizer Inc Recent Development
Table 87. Lilly Company Information
Table 88. Lilly Introduction and Business Overview
Table 89. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Lilly PD-1 and PD-L1 Drug Product Offerings
Table 91. Lilly Recent Development
Table 92. Novartis AG Company Information
Table 93. Novartis AG Introduction and Business Overview
Table 94. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Novartis AG PD-1 and PD-L1 Drug Product Offerings
Table 96. Novartis AG Recent Development
Table 97. GSK Company Information
Table 98. GSK Introduction and Business Overview
Table 99. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. GSK PD-1 and PD-L1 Drug Product Offerings
Table 101. GSK Recent Development
Table 102. Junshi Biosciences Company Information
Table 103. Junshi Biosciences Introduction and Business Overview
Table 104. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Junshi Biosciences PD-1 and PD-L1 Drug Product Offerings
Table 106. Junshi Biosciences Recent Development
Table 107. Akeso, Inc Company Information
Table 108. Akeso, Inc Introduction and Business Overview
Table 109. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Akeso, Inc PD-1 and PD-L1 Drug Product Offerings
Table 111. Akeso, Inc Recent Development
Table 112. BeiGene Company Information
Table 113. BeiGene Introduction and Business Overview
Table 114. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. BeiGene PD-1 and PD-L1 Drug Product Offerings
Table 116. BeiGene Recent Development
Table 117. Innovent Company Information
Table 118. Innovent Introduction and Business Overview
Table 119. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Innovent PD-1 and PD-L1 Drug Product Offerings
Table 121. Innovent Recent Development
Table 122. Jiangsu Hengrui Medicine Co.,Ltd Company Information
Table 123. Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
Table 124. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Offerings
Table 126. Jiangsu Hengrui Medicine Co.,Ltd Recent Development
Table 127. Cstone Company Information
Table 128. Cstone Introduction and Business Overview
Table 129. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Cstone PD-1 and PD-L1 Drug Product Offerings
Table 131. Cstone Recent Development
Table 132. Henlius Company Information
Table 133. Henlius Introduction and Business Overview
Table 134. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Henlius PD-1 and PD-L1 Drug Product Offerings
Table 136. Henlius Recent Development
Table 137. Simcere Pharmaceutical Group Limited Company Information
Table 138. Simcere Pharmaceutical Group Limited Introduction and Business Overview
Table 139. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Offerings
Table 141. Simcere Pharmaceutical Group Limited Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. PD-1 and PD-L1 Drug Downstream Customers
Table 145. PD-1 and PD-L1 Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Drug Product Picture
Figure 2. Global PD-1 and PD-L1 Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global PD-1 and PD-L1 Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global PD-1 and PD-L1 Drug Sales Price (2019-2030) & (US$/Unit)
Figure 6. PD-1 and PD-L1 Drug Report Years Considered
Figure 7. Global PD-1 and PD-L1 Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global PD-1 and PD-L1 Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Drug Revenue in 2023
Figure 10. PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. PD-1 Monoclonal Antibody Picture
Figure 12. PD-L1 Monoclonal Antibody Picture
Figure 13. Global PD-1 and PD-L1 Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global PD-1 and PD-L1 Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global PD-1 and PD-L1 Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global PD-1 and PD-L1 Drug Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Liver Cancer
Figure 19. Product Picture of Esophageal Cancer
Figure 20. Product Picture of Nasal Cancer
Figure 21. Product Picture of Stomach Cancer
Figure 22. Product Picture of Other
Figure 23. Global PD-1 and PD-L1 Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global PD-1 and PD-L1 Drug Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global PD-1 and PD-L1 Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global PD-1 and PD-L1 Drug Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. North America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. South America PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. South America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume (%), (2019-2030)
Figure 40. United States PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. United States PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. China PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. China PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. China PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. India PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 59. India PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 60. India PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 61. PD-1 and PD-L1 Drug Industrial Chain
Figure 62. PD-1 and PD-L1 Drug Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. PD-1 and PD-L1 Drug Market Trends
Table 2. PD-1 and PD-L1 Drug Market Drivers & Opportunity
Table 3. PD-1 and PD-L1 Drug Market Challenges
Table 4. PD-1 and PD-L1 Drug Market Restraints
Table 5. Global PD-1 and PD-L1 Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2019-2024)
Table 7. Global PD-1 and PD-L1 Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market PD-1 and PD-L1 Drug Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers PD-1 and PD-L1 Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers PD-1 and PD-L1 Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of PD-1 and PD-L1 Drug
Table 13. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global PD-1 and PD-L1 Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global PD-1 and PD-L1 Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global PD-1 and PD-L1 Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global PD-1 and PD-L1 Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global PD-1 and PD-L1 Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global PD-1 and PD-L1 Drug Price by Type (2019-2024) & (US$/Unit)
Table 27. Global PD-1 and PD-L1 Drug Price by Type (2025-2030) & (US$/Unit)
Table 28. Global PD-1 and PD-L1 Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global PD-1 and PD-L1 Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global PD-1 and PD-L1 Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global PD-1 and PD-L1 Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global PD-1 and PD-L1 Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global PD-1 and PD-L1 Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global PD-1 and PD-L1 Drug Price by Application (2019-2024) & (US$/Unit)
Table 39. Global PD-1 and PD-L1 Drug Price by Application (2025-2030) & (US$/Unit)
Table 40. Global PD-1 and PD-L1 Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global PD-1 and PD-L1 Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global PD-1 and PD-L1 Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global PD-1 and PD-L1 Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global PD-1 and PD-L1 Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global PD-1 and PD-L1 Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global PD-1 and PD-L1 Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global PD-1 and PD-L1 Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Bristol Myers Squibb Company Information
Table 58. Bristol Myers Squibb Introduction and Business Overview
Table 59. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bristol Myers Squibb PD-1 and PD-L1 Drug Product Offerings
Table 61. Bristol Myers Squibb Recent Development
Table 62. Merck & Co., Inc. Company Information
Table 63. Merck & Co., Inc. Introduction and Business Overview
Table 64. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Merck & Co., Inc. PD-1 and PD-L1 Drug Product Offerings
Table 66. Merck & Co., Inc. Recent Development
Table 67. F. Hoffmann -La Roche Ltd Company Information
Table 68. F. Hoffmann -La Roche Ltd Introduction and Business Overview
Table 69. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Offerings
Table 71. F. Hoffmann -La Roche Ltd Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca PD-1 and PD-L1 Drug Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi PD-1 and PD-L1 Drug Product Offerings
Table 81. Sanofi Recent Development
Table 82. Pfizer Inc Company Information
Table 83. Pfizer Inc Introduction and Business Overview
Table 84. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Inc PD-1 and PD-L1 Drug Product Offerings
Table 86. Pfizer Inc Recent Development
Table 87. Lilly Company Information
Table 88. Lilly Introduction and Business Overview
Table 89. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Lilly PD-1 and PD-L1 Drug Product Offerings
Table 91. Lilly Recent Development
Table 92. Novartis AG Company Information
Table 93. Novartis AG Introduction and Business Overview
Table 94. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Novartis AG PD-1 and PD-L1 Drug Product Offerings
Table 96. Novartis AG Recent Development
Table 97. GSK Company Information
Table 98. GSK Introduction and Business Overview
Table 99. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. GSK PD-1 and PD-L1 Drug Product Offerings
Table 101. GSK Recent Development
Table 102. Junshi Biosciences Company Information
Table 103. Junshi Biosciences Introduction and Business Overview
Table 104. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Junshi Biosciences PD-1 and PD-L1 Drug Product Offerings
Table 106. Junshi Biosciences Recent Development
Table 107. Akeso, Inc Company Information
Table 108. Akeso, Inc Introduction and Business Overview
Table 109. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Akeso, Inc PD-1 and PD-L1 Drug Product Offerings
Table 111. Akeso, Inc Recent Development
Table 112. BeiGene Company Information
Table 113. BeiGene Introduction and Business Overview
Table 114. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. BeiGene PD-1 and PD-L1 Drug Product Offerings
Table 116. BeiGene Recent Development
Table 117. Innovent Company Information
Table 118. Innovent Introduction and Business Overview
Table 119. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Innovent PD-1 and PD-L1 Drug Product Offerings
Table 121. Innovent Recent Development
Table 122. Jiangsu Hengrui Medicine Co.,Ltd Company Information
Table 123. Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
Table 124. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Offerings
Table 126. Jiangsu Hengrui Medicine Co.,Ltd Recent Development
Table 127. Cstone Company Information
Table 128. Cstone Introduction and Business Overview
Table 129. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Cstone PD-1 and PD-L1 Drug Product Offerings
Table 131. Cstone Recent Development
Table 132. Henlius Company Information
Table 133. Henlius Introduction and Business Overview
Table 134. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Henlius PD-1 and PD-L1 Drug Product Offerings
Table 136. Henlius Recent Development
Table 137. Simcere Pharmaceutical Group Limited Company Information
Table 138. Simcere Pharmaceutical Group Limited Introduction and Business Overview
Table 139. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Offerings
Table 141. Simcere Pharmaceutical Group Limited Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. PD-1 and PD-L1 Drug Downstream Customers
Table 145. PD-1 and PD-L1 Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Drug Product Picture
Figure 2. Global PD-1 and PD-L1 Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global PD-1 and PD-L1 Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global PD-1 and PD-L1 Drug Sales Price (2019-2030) & (US$/Unit)
Figure 6. PD-1 and PD-L1 Drug Report Years Considered
Figure 7. Global PD-1 and PD-L1 Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global PD-1 and PD-L1 Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Drug Revenue in 2023
Figure 10. PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. PD-1 Monoclonal Antibody Picture
Figure 12. PD-L1 Monoclonal Antibody Picture
Figure 13. Global PD-1 and PD-L1 Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global PD-1 and PD-L1 Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global PD-1 and PD-L1 Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global PD-1 and PD-L1 Drug Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Liver Cancer
Figure 19. Product Picture of Esophageal Cancer
Figure 20. Product Picture of Nasal Cancer
Figure 21. Product Picture of Stomach Cancer
Figure 22. Product Picture of Other
Figure 23. Global PD-1 and PD-L1 Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global PD-1 and PD-L1 Drug Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global PD-1 and PD-L1 Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global PD-1 and PD-L1 Drug Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. North America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. South America PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. South America PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa PD-1 and PD-L1 Drug Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa PD-1 and PD-L1 Drug Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions PD-1 and PD-L1 Drug Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions PD-1 and PD-L1 Drug Sales Volume (%), (2019-2030)
Figure 40. United States PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. United States PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. China PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. China PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. China PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 58. India PD-1 and PD-L1 Drug Sales Value, (2019-2030) & (US$ Million)
Figure 59. India PD-1 and PD-L1 Drug Sales Value by Type (%), 2023 VS 2030
Figure 60. India PD-1 and PD-L1 Drug Sales Value by Application (%), 2023 VS 2030
Figure 61. PD-1 and PD-L1 Drug Industrial Chain
Figure 62. PD-1 and PD-L1 Drug Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Digital Multifunction Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Whole Current Energy Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
High Current Air Circuit Breaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232